Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients

Clinical Cancer Research

Volumn 15, Issue 20, 2009, Pages 6378-6385

  Erlic, Zoran ^a   Rybicki, Lisa ^b,c   Peczkowska, Mariola ^d   Golcher, Henriette ^e   Kann, Peter H ^f   Brauckhoff, Michael ^g,h   Müssig, Karsten ⁱ   Muresan, Michaela ^j   Schäffler, Andreas ^k   Reisch, Nicole ^l   Schott, Matthias ^m   Fassnacht, Martin ⁿ   Opocher, Giuseppe ^o   Klose, Silke ^p   Fottner, Christian ^q   Forrer, Flavio ^r   Plöckinger, Ursula ^s   Petersenn, Stephan ^t   Zabolotny, Dimitry ^v   Kollukch, Oleg ^w   Yaremchuk, Svetlana ^v   Januszewicz, Andrzej ^d   Walz, Martin K ^u   Eng, Charis ^b,c   Neumann, Hartmut P H ^a   more..

^a UNIVERSITY OF FREIBURG   (Germany)

^b LERNER RESEARCH INSTITUTE   (United States)

^c TAUSSIG CANCER INSTITUTE   (United States)

^d INSTITUTE OF CARDIOLOGY   (Poland)

^e UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^f UNIVERSITY HOSPITAL MARBURG   (Germany)

^g HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^h MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

ⁱ UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^j Bon Secours Hospital   (France)

^k UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^l LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^m UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

ⁿ UNIVERSITY OF WÜRZBURG   (Germany)

^o UNIVERSITY OF PADOVA   (Italy)

^p OTTO VON GUERICKE UNIVERSITY   (Germany)

^q UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^r UNIVERSITY HOSPITAL BASEL   (Switzerland)

^s CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^t UNIVERSITY OF DUISBURG ESSEN   (Germany)

^u Department of Surgery   (Germany)

^v Ukranian Strazhesko Institute of Cardiology   (Ukraine)

^w V P Komisarenko Institute of Endocrinology and Metabolism of the Ukraine Academy of Medical Sciences   (Ukraine)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN RET; SUCCINATE DEHYDROGENASE; VON HIPPEL LINDAU PROTEIN;

ADULT; ALGORITHM; ARTICLE; BOOTSTRAPPING; CHEMODECTOMA; CLINICAL FEATURE; CLINICAL LABORATORY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETICS; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MUTATION; NUCLEOTIDE SEQUENCE; PARAGANGLIOMA; PARAMETER; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RET GENE; SDHB GENE; SDHD GENE; VHL GENE;

ADRENAL GLAND NEOPLASMS; ALGORITHMS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEAD AND NECK NEOPLASMS; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; MUTATION; PARAGANGLIOMA; PHEOCHROMOCYTOMA;

EID: 70350217774     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-1237     Document Type: Article

References (36)

1. DeLellis RA, Lloyd RV, Heitz PU, Eng C. DeLellis RA, Lloyd RV, Heitz PU, editors. World Health Organization classification of tumours: pathology and genetics of tumours of endocrine organs. Lyon: IARC Press; 2004.
2. Neumann HP, Bausch B, McWhinney SR, et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002;346:1459-1466
3. Neumann H. Pheochromocytoma. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison's Principles of Internal Medicine 17th ed. New York: The McGraw-Hill; 2008, p. 2269-2275
4. Erlic Z, Neumann HP. Clinical question: When should genetic testing be obtained in a patient with pheochromocytoma or paraganglioma? Clin Endocrinol (Oxf) 2009;70:354-357
5. Bausch B, Borozdin W, Neumann HP. Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma. N Engl J Med 2006;354:2729-2731 (Pubitemid 43920863)
6. Neumann HP, Pawlu C, Peczkowska M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004;292:943-951 (Pubitemid 39097204)
7. Amar L, Bertherat J, Baudin E, et al. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005;23:8812-8818 (Pubitemid 46211527)
8. Benn DE, Gimenez-Roqueplo AP, Reilly JR, et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 2006;91:827-836
9. Neumann HP, Vortmeyer A, Schmidt D, et al. Evidence of MEN-2 in the original description of classic pheochromocytoma. N Engl J Med 2007;357:1311-1315 (Pubitemid 47481453)
10. Baysal BE. Clinical and molecular progress in hereditary paraganglioma. J Med Genet 2008;45: 689-694
11. Neumann HP, Erlic Z, Boedeker CC, et al. Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res 2009;69:3650-3656
12. Peczkowska M, Cascon A, Prejbisz A, et al. Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation. Nat Clin Pract Endocrinol Metab 2008;4:111-115 (Pubitemid 351156901)
13. Mannelli M, Ercolino T, Giache V, Simi L, Cirami C, Parenti G. Genetic screening for pheochromocytoma: Should SDHC gene analysis be included? J Med Genet 2007;44:586-587
14. Brauch H, Kishida T, Glavac D, et al. Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Hum Genet 1995; 95:551-556
15. Schiavi F, Boedeker CC, Bausch B, et al. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 2005;294:2057-2063 (Pubitemid 41539939)
16. Bausch B, Koschker A-C, Fassnacht M, et al. Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma. J Clin Endocrinol Metab 2006;91:3478-3481 (Pubitemid 44402122)
17. Baysal BE, Willett-Brozick JE, Filho PA, Lawrence EC, Myers EN, Ferrell RE. An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma. J Med Genet 2004;41:703-709
18. Cascon A, Montero-Conde C, Ruiz-Llorente S, et al. Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot? Genes Chromosomes Cancer 2006;45:213-219
19. McWhinney SR, Pilarski RT, Forrester SR, et al. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma. J Clin Endocrinol Metab 2004; 89:5694-5699
20. Stolle C, Glenn G, Zbar B, et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 1998;12:417-423 (Pubitemid 28512618)
21. Amar L, Baudin E, Burnichon N, et al. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J Clin Endocrinol Metab 2007;92:3822-3828 (Pubitemid 47607629)
22. Reisch N, Walz MK, Erlic Z, Neumann HP. [Pheochromocytoma - still a challenge.]. Der Internist 2009;50:27-35.
23. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003;21:2397-2406 (Pubitemid 46908372)
24. Gimenez-Roqueplo AP, Lehnert H, Mannelli M, et al. Phaeochromocytoma, new genes and screening strategies. Clin Endocrinol (Oxf) 2006;65:699-705. (Pubitemid 44773690)
25. Pigny P, Cardot-Bauters C, Do Cao C, et al. Should genetic testing be performed in each patient with sporadic pheochromocytoma at presentation? Eur J Endocrinol 2009;160:227-231
26. Cascón A, López-Jiménez E, Landa I, et al. Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma. Horm Metab Res 2009;41: 672-675
27. Pacak K, Eisenhofer G, Ahlman H, et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 2007;3:92-102. (Pubitemid 46146962)
28. Thorlacius S, Olafsdottir G, Tryggvadottir L, et al. A single BRCA2 mutation inmale and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 1996;13:117-119 (Pubitemid 126528241)
29. Tryggvadottir L, Sigvaldason H, Olafsdottir GH, et al. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000. J Natl Cancer Inst 2006;98:116-122
30. Simi L, Sestini R, Ferruzzi P, et al. Phenotype variability of neural crest derived tumours in six Italian families segregating the same founder SDHD mutation Q109X. J Med Genet 2005; 42:e52.
31. Taschner PE, Jansen JC, Baysal BE, et al. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer 2001;31:274-281
32. Schiavi F, Erlic Z, Savvoukidis T, et al. A founder mutation in the SDHD gene as the cause of the high prevalence ofHead and Neck Paraganglioma in Trentino, Italy. J Hypertens 2006;24:S327-S.
33. Cascon A, Landa I, Lopez-Jimenez E, et al. Molecular characterisation of a common SDHB deletion in paraganglioma patients. J Med Genet 2008;45:233-238
34. Peczkowska M, Erlic Z, Hoffmann MM, et al. Impact of screening kindreds for SDHD p. Cys11X as a common mutation associated with paraganglioma syndrome type 1. J Clin Endocrinol Metab 2008;93:4818-4825
35. Dahia PL, Hao K, Rogus J, et al. Novel pheochromocytoma susceptibility loci identified by integrative genomics. Cancer Res 2005;65: 9651-9658 (Pubitemid 41541440)
36. Opocher G, Schiavi F, Iacobone M, et al. Familial nonsyndromic pheochromocytoma. Ann N Y Acad Sci 2006;1073:149-155